Asim Rafique MD (@arafiqmd1) 's Twitter Profile
Asim Rafique MD

@arafiqmd1

Interventional Cardiologist @UCLAHealth

ID: 1259228270710583296

linkhttps://www.uclahealth.org/asim-rafique calendar_today09-05-2020 21:13:44

55 Tweet

136 Followers

161 Following

Sanjum S. Sethi MD, MPH (@sanjum) 's Twitter Profile Photo

Coronavirus May Be a Blood Vessel Disease, Which Explains Everything by Dana Smith in Elemental Does endothelial dysfunction tie everything together? #COVID19. We have much to learn! @MRMehraMD elemental.medium.com/coronavirus-ma…

Jonathan Reiner (@jreinermd) 's Twitter Profile Photo

I’m on STEMI call tomorrow. I’ve been on call during blizzards and inauguration and the 4th of July but never during active riots. I haven’t given a single dose of lytic in my entire career. Now I’m wondering what is right for my team.

Gregg Fonarow MD (@gcfmd) 's Twitter Profile Photo

“the Surgisphere case raises a bigger question about how much access to key data each author and each journal should require. “The less access they have, the greater the chances that there will be errors, data fabrication, or outright fraud.” sciencemag.org/news/2020/06/t…

Asim Rafique MD (@arafiqmd1) 's Twitter Profile Photo

Low standard for #COVID19 and fool's gold in the #Surgisphere data sand box “They talk about propensity scores, this huge database from 169 hospitals, five continents, it sounds fancy, and people started latching to this study out of hope” Chaccour says"gu.com/p/exemb/stw

Gregg Fonarow MD (@gcfmd) 's Twitter Profile Photo

And even more strangely, for studies that claimed a massive feat of data integration in record-setting time, they had no biostatisticians listed as authors that might have helped pull all this data together. The Tiny Data Firm - Bloomberg bloomberg.com/news/articles/…

Asim Rafique MD (@arafiqmd1) 's Twitter Profile Photo

Behi Rabbani, MD⁩ ⁦Rushi Parikh⁩ ⁦Gregg Fonarow MD⁩ ⁦Eric Topol⁩ ⁦Anthony Fauci 😷.⁩ Colchicine for the Treatment of Myocardial Injury in Patients With Coronavirus Disease 2019 #COVID19—An Old Drug With New Life? jamanetwork.com/journals/jaman…

UCLA Health (@uclahealth) 's Twitter Profile Photo

Congrats to our inaugural #UCLABiodesign graduates! Tasked with driving health care innovation amid the unexpected #COVID19 pandemic, the team delivered far beyond expectations. Desert #UCLAInnovates Learn more about their advancements. ➨ ucla.in/2NOW6cz

Congrats to our inaugural #UCLABiodesign graduates! Tasked with driving health care innovation amid the unexpected #COVID19 pandemic, the team delivered far beyond expectations. <a href="/innovateshealth/">Desert</a> #UCLAInnovates

Learn more about their advancements. ➨ ucla.in/2NOW6cz
Rushi Parikh (@rushiparikh11) 's Twitter Profile Photo

Encouraging/hypothesis-generating data from GRECCO-19 re: Colchicine in COVID-19. More data forthcoming via large outpatient-based COLCORONA trial and UCLA Health inpatient-based COLHEART-19 trial in pts w/ cardiac injury. Please DM if interested in joining COLHEART-19.

Gregg Fonarow MD (@gcfmd) 's Twitter Profile Photo

DAPA-CKD “also met all its secondary endpoints in CKD patients with and without type-2 diabetes (T2D), making dapagliflozin the first medicine to significantly reduce the risk of death from any cause in this patient population.” ⁦HFSA⁩ ⁦ astrazeneca.com/media-centre/p…

UCLA Health (@uclahealth) 's Twitter Profile Photo

Number 1 🥇 in #California and top 4 in the nation. We’re proud to be named California’s top hospital once again by U.S. News & World Report (U.S. News & World Report): uclahealth.org/c-usnwr #BestHospitals

Gregg W. Stone MD (@greggwstone) 's Twitter Profile Photo

Interesting study online in JACC from 5 major FFR studies (n=5129) - in pts with ACS lesions deferred with FFR >0.80 have higher MACE than in stable CAD. Most likely (IMO) due to vulnerable plaques despite being non-flow limiting. No difference in outcomes for treated lesions.

Interesting study online in JACC from 5 major FFR studies (n=5129) - in pts with ACS lesions deferred with FFR &gt;0.80 have higher MACE than in stable CAD. Most likely (IMO) due to vulnerable plaques despite being non-flow limiting. No difference in outcomes for treated lesions.
Gregg Fonarow MD (@gcfmd) 's Twitter Profile Photo

Acute myocardial infarction in the young with diabetes mellitus- national inpatient sample study with sex-based difference in outcomes internationaljournalofcardiology.com/article/S0167-…

Tommaso Scquizzato, MD (@tscquizzato) 's Twitter Profile Photo

OHCA in Los Angeles increased (+21%) while STEMI decreased (-7%) following the stay-at-home order. Increased OHCA (with lower ROSC and higher EMS response time) was not fully explained by STEMI reduction. 🔗 JAHA ahajournals.org/doi/10.1161/JA… #FOAMres #CardioTwitter ResusBot 🤖❤️⚡️

OHCA in Los Angeles increased (+21%) while STEMI decreased (-7%) following the stay-at-home order.
Increased OHCA (with lower ROSC and higher EMS response time) was not fully explained by STEMI reduction. 
🔗 <a href="/JAHA_AHA/">JAHA</a> ahajournals.org/doi/10.1161/JA…
#FOAMres #CardioTwitter <a href="/Resus_Bot/">ResusBot 🤖❤️⚡️</a>
Asim Rafique MD (@arafiqmd1) 's Twitter Profile Photo

When suspecting heart attack or stroke, every minute counts so don't delay medical care due to COVID-19 and call 911. OHCA in Los Angeles increased (+21%) while STEMI decreased (-7%) following the stay-at-home order ahajournals.org/doi/10.1161/JA… Weiyi Tan, MD, MPH Gregg Fonarow MD UCLA Health